Test-retest of computerized health status questionnaires frequently used in the monitoring of knee osteoarthritis: a randomized crossover trial

Gudbergsen, Henrik; Bartels, Else Marie; Krusager, Peter; Wæhrens, Eva Ejlersen; Christensen, Robin; Danneskiold‐Samsøe, Bente; Bliddal, Henning

doi:10.1186/1471-2474-12-190

Cited by 57 publications

(37 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The scale can be self‐administered or administered by a health care professional. There are some translations to other languages, and a computerized version is also available …”

Section: Resultsmentioning

confidence: 99%

Rating Scales for Pain in Parkinson's Disease: Critique and Recommendations

Pérez-Lloret

Andrade

Lyons

et al. 2016

Movement Disord Clin Pract

View full text Add to dashboard Cite

Background We aimed at critically appraising the clinimetric properties of existing pain scales or questionnaires and to give recommendations for their use in Parkinson's disease (PD). Methods Clinimetric properties of pain scales used in PD were systematically evaluated. A scale was classified as ‘recommended’ if was used in PD, showed adequate clinimetric properties, and had been used by investigators other than the original developers; as ‘suggested’ if it was used in PD and fulfilled only one other criterion; and as ‘listed’ if it was used in PD but did not meet the other criteria. Only scales rating pain intensity or for syndromic classification were assessed. Results Eleven of the 34 scales initially considered fulfilled inclusion criteria. Among the scales rating pain intensity, the “Brief Pain Inventory short form,” “McGill Pain Questionnaire short and long forms,” “Neuropathic Pain Symptoms Inventory,” “11‐point Numeric Rating Scale,” “10‐cm Visual Analog Scale,” and “Pain‐O‐Meter” were “recommended with caution” because of lack of clinimetric data in PD, whereas the “King's PD Pain Scale” was “recommended.” Among scales for pain syndromic classification, the “DN4” was “recommended with caution” because of lack of clinimetric data in PD; the “Leeds Assessment of Neuropathic Symptoms and Signs,” “Pain‐DETECT,” and the “King's PD Pain Scale” were “suggested.” Conclusions King's PD pain scale can be recommended for the assessment of pain intensity in PD. Syndromic classification of pain in PD may be achieved by the DN4, but clinimetric data in PD are needed for this scale.

show abstract

“…The scale can be self‐administered or administered by a health care professional. There are some translations to other languages, and a computerized version is also available …”

Section: Resultsmentioning

confidence: 99%

Rating Scales for Pain in Parkinson's Disease: Critique and Recommendations

Pérez-Lloret

Andrade

Lyons

et al. 2016

Movement Disord Clin Pract

View full text Add to dashboard Cite

show abstract

“…At 1 year post‐ACLR, the KOOS was completed in person (pen and paper), while at 3 years post‐ACLR, the KOOS was completed via an online portal (MySQL, Oracle Corporation), with identical instructions to the original paper version. KOOS has demonstrated test–retest reliability between paper and electronic formats (intraclass correlation coefficient >0.96) . Participants without access to email at followup (n = 5) were mailed a hard copy of the KOOS to complete and return by post.…”

Section: Methodsmentioning

confidence: 99%

Early Patellofemoral Osteoarthritis Features One Year After Anterior Cruciate Ligament Reconstruction: Symptoms and Quality of Life at Three Years

Culvenor

Collins

Guermazi

et al. 2016

Arthritis Care & Research

View full text Add to dashboard Cite

Objective. To determine whether the presence of magnetic resonance imaging (MRI) osteoarthritis (OA) features in the patellofemoral or tibiofemoral joint (i.e., bone marrow lesions, cartilage lesions, and osteophytes) and/or functional impairments, 1 year following anterior cruciate ligament reconstruction (ACLR), can predict Knee Injury and Osteoarthritis Outcome Score (KOOS) at 3 years. Methods. A total of 93 participants (56 [60%] men, mean 6 SD age 29 6 9 years) who had undergone MRI examination and functional testing at 1-year post-ACLR, completed the KOOS at 3 years postsurgery. Multivariate regression models evaluated the prognostic capacity of compartment-specific osteochondral OA features, scored using the MRI Osteoarthritis Knee Score, and functional performance (hop for distance, 1-leg rise), to predict outcome on 4 KOOS subscales (pain, symptoms, sport/recreation, and quality of life [QOL]). Results. Presence of patellofemoral cartilage lesions 1-year post-ACLR predicted worse score on all KOOS subscales at 3 years (P £ 0.01). Regression coefficients (B) were 25.1 (95% confidence interval [95% CI] 29.1, 21.2) for symptoms, 24.0 (95% CI 26.7, 21.4) for pain, 26.7 (95% CI 211.0, 22.4) for sport/recreation, and 28.6 (95% CI 215.1, 22.1) for QOL. No significant associations were found between tibiofemoral MRI features and knee symptoms. Poorer performance on the 1-leg-rise test predicted worse KOOS-QOL (B 26.5 [95% CI 212.4,20.5], P 5 0.03). Conclusion. The presence of a patellofemoral articular cartilage lesion and lower 1-leg-rise performance at 1 year postsurgery are prognostic for poorer 3-year outcome following ACLR. Particular attention to patellofemoral compartment lesions and functional capacity is warranted during postoperative rehabilitation programs, as these features represent potential targets for therapy aimed at minimizing symptomatic disease progression in these young adults.

show abstract

“…Patient reported outcomes were examined at baseline and after 16 weeks by assessing the OMERACT-OARSI Responder Criteria and KOOS pain and function in daily living (ADL), which were completed by the patients on a validated touch screen solution [33]. …”

Section: Methodsmentioning

confidence: 99%

Changes in bone marrow lesions in response to weight-loss in obese knee osteoarthritis patients: a prospective cohort study

Gudbergsen

Boesen

Christensen

et al. 2013

BMC Musculoskelet Disord

Self Cite

View full text Add to dashboard Cite

BackgroundPatients are susceptible for knee osteoarthritis (KOA) with increasing age and obesity and KOA is expected to become a major disabling disease in the future. An important feature of KOA on magnetic resonance imaging (MRI) is changes in the subchondral bone, bone marrow lesions (BMLs), which are related to the future degeneration of the knee joint as well as prevalent clinical symptoms. The aim of this study was to investigate the changes in BMLs after a 16-week weight-loss period in obese subjects with KOA and relate changes in BMLs to the effects of weight-loss on clinical symptoms.MethodsThis prospective cohort study included patients with a body mass index ≥ 30 kg/m2, an age ≥ 50 years and primary KOA. Patients underwent a 16 weeks supervised diet program which included formula products and dietetic counselling (ClinicalTrials.gov: NCT00655941). BMLs in tibia and femur were assessed on MRI before and after the weight-loss using the Boston-Leeds Osteoarthritis Knee Score. Response to weight-loss in BML scores was dichotomised to patients experiencing a decrease in BML scores (responders) and patients who did not (non-responders). The association of BMLs to weight-loss was assessed by logistic regressions and correlation analyses.Results39 patients (23%) were classified as responders in the sum of all BML size scores whereas 130 patients (77%) deteriorated or remained stable and were categorized as non-responders. Logistic regression analyses revealed no association between weight-loss < or ≥ 10% and response in BMLs in the most affected compartment (OR 1.86 [CI 0.66 to 5.26, p=0.24]). There was no association between weight-loss and response in maximum BML score (OR 1.13 [CI 0.39 to 3.28, p=0.81]). The relationship between changes in BMLs and clinical symptoms revealed that an equal proportion of patients classified as BML responders and non-responders experienced an OMERACT-OARSI response (69 vs. 71%, p=0.86).ConclusionsWeight-loss did not improve the sum of tibiofemoral BML size scores or the maximum tibiofemoral BML score, suggesting that BMLs do not respond to a rapidly decreased body weight. The missing relationship between clinical symptoms and BMLs calls for further investigation.

show abstract

Test-retest of computerized health status questionnaires frequently used in the monitoring of knee osteoarthritis: a randomized crossover trial

Cited by 57 publications

References 28 publications

Rating Scales for Pain in Parkinson's Disease: Critique and Recommendations

Rating Scales for Pain in Parkinson's Disease: Critique and Recommendations

Early Patellofemoral Osteoarthritis Features One Year After Anterior Cruciate Ligament Reconstruction: Symptoms and Quality of Life at Three Years

Changes in bone marrow lesions in response to weight-loss in obese knee osteoarthritis patients: a prospective cohort study

Contact Info

Product

Resources

About